Transfection of human endothelial cells with HIV-1 tat gene activates NF-κB and enhances monocyte adhesion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Pieper, Galen M ^a,c   Olds, Cara L ^b   Bub, Jeffrey D ^c   Lindholm, Paul F ^c,d  

^a Division of Pediatric Surgery   (United States)

^b Cardiovascular Research Center   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cell adhesion; Endothelium; Human immunodeficiency virus; Nuclear factor B; Signal transduction; Viral protein

Indexed keywords

ACETYLSALICYLIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LUCIFERASE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CELL ADHESION; DNA VECTOR; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA VIRUS; MONOCYTE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

EID: 0036889938     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00469.2002     Document Type: Article

References (40)

1. 3 integrin. J Immunol 163: 1929-1935, 1999.
2. Buonaguro L, Buonaguro FM, Giraldo G, and Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor-β gene expression through a TAR-like structure. J Virol 68: 2677-2682, 1994.
3. Chen F, Lu Y, Castranova V, Rojanasakul Y, Miyahara K, Shizuta Y, Vallyathan V, Shi X, and Demers LM. Nitric oxide inhibits HIV-1 Tat-induced NF-κB activation. Am J Pathol 155: 275-284, 1999.
4. Chetty R, Batitang S, and Nair R. Large artery vasculopathy in HIV-positive patients: Another vasculitic enigma. Hum Pathol 31: 374-379, 2000.
5. 2-glycoprotein I in HIV-seropositive patients: Relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 28: 115-122, 1998.
6. Cooper M, Lindholm P, Pieper G, Seibel R, Moore G, Nakanishi A, Dembny K, Komorowski R, Johnson C, Adams M, and Roza A. Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts. Transplantation 66: 838-844, 1998.
7. Corallini A, Altavilla G, Pozzi L, Bignozzi F, Negrini M, Rimessi P, Gualandi F, and Barbanti-Brodano G. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 53: 5569-5575, 1993.
8. Demarchi F, D'Adda DiFagagna F, Falaschi A, and Giacca M. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J Virol 70: 4427-4437, 1996.
9. Dhawan S, Weeks BS, Soderland C, Schnaper HW, Toro LA, Asthana SP, Hewlett IK, Stetler-Stevenson WG, Yamada SS, and Yamada KM. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 154: 422-432, 1995.
10. Dollard SC, James HJ, Sharer LR, Epstein LG, Gelbard HA, and Dewhurst S. Activation of nuclear factor κB in brains from children with HIV-1 encephalitis. Neuropathol Appl Neurobiol 21: 518-528, 1995.
11. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, and Gallo R. Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287, 1993.
12. Hofman FM, Chen P, Incardona F, Zidovetzki R, and Hinton DR. HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J Neuroimmunol 94: 28-39, 1999.
13. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, and Walker SM. Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunity 54: 19-28, 1999.
14. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, and Walker SM. Exogenous tat protein activates human endothelial cells. Blood 82: 2774-2780, 1993.
15. Kolson DL, Collman R, Hrin R, Balliet JW, Laughlin M, McGann KA, Debouck C, and Gonzalezscarano F. Human immunodeficiency virus type 1 Tat activity in neuronal cells: Uptake and transactivation. J Gen Virol 75: 927-934, 1994.
16. Krachmarov CP, Chepenik LG, Barr-Vagell S, Khalili K, and Johnson EM. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Purα. Proc Natl Acad Sci USA 93: 14112-14117, 1996.
17. Kumar A, Dhawan S, Mukhopadhyay A, and Aggarwal BB. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-κB. FEBS Lett 462: 140-144, 1999.
18. Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J, Lee BR, Jin LH, Park J, and Choi SY. Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett 485: 163-167, 2000.
19. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, and Dhawan S. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 156: 1638-1645, 1996.
20. Lewis W. Atherosclerosis in AIDS: Potential pathogenic roles of antiretroviral therapy and HIV. J Mol Cell Cardiol 32: 2115-2129, 2000.
21. Lindholm PF, Tamami M, Makowski J, and Brady JN. Human T-cell lymphotropic type 1 Tax activation of NF-κB: Involvement of the protein kinase C pathway. J Virol 70: 2525-2532, 1996.
22. Ma M and Nath A. Molecular determinants of cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499, 1997.
23. Metzgar AU, Bayer P, Willbold D, Hoffmann S, Frank RW, Goody RS, and Rösch P. The interaction of HIV-1 Tat (32-72) with its target RNA: A fluorescence and nuclear magnetic resonance study. Biochem Biophys Res Commun 241: 31-36, 1997.
24. Ott M, Lovett JL, Mueller L, and Verdin E. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-κB factors. J Immunol 60: 2872-2880, 1998.
25. Pieper GM and ul-Haq R. Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C. J Cardiovasc Pharmacol 30: 528-532, 1997.
26. Raidel SM, Haase C, Jansen NR, Russ RB, Sutliff RL, Velsor LW, Day BJ, Hoit BD, Samarel AM, and Lewis W. Targeted myocardial transgenic expression of HIV 1 Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 282: H1672-H1678, 2002.
27. Read MA, Whitley MZ, Williams AJ, and Collins T. NF-κB and IκBα: An inducible regulatory system in endothelial activation. J Exp Med 179: 503-512, 1994.
28. Roza A, Cooper M, Pieper G, Hilton G, Dembny K, Lai CS, Lindholm P, Komorowski R, Felix C, Johnson C, and Adams M. NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation 69: 227-231, 2000.
29. Schreck R, Grassmann R, Fleckenstein B, and Baeuerle PA. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type 1 Tax protein. J Virol 66: 6288-6293, 1992.
30. Schwarze SR and Dowdy SF. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21: 45-48, 2000.
31. Seigneur M, Constans J, Blann A, Renard M, Pellegrin JL, Amiral J, Boisseau M, and Conri C. Soluble adhesion molecules and endothelial cell damage in HIV-infected patients. Thromb Haemost 77: 646-649, 1997.
32. Sun SC, Elwood J, and Greene WC. Both amino- and carboxyl-terminal sequences with IκBα regulate its inducible degradation. Mol Cell Biol 16: 1058-1065, 1996.
33. Taylor JP, Pomerantz R, Bagasra O, Chowdhury M, Rappaport J, Khalili K, and Amini S. TAR-independent transactivation by Tat in cells derived from the CNS: A novel mechanism of HIV-1 gene regulation. EMBO J 11: 3395-3403, 1992.
34. Terada LS, Gu Y, and Flores SC. AIDS vasculopathy. Am J Med Sci 320: 379-387, 2000.
35. Toneatto S, Finco O, van der Putten H, Abrignani S, and Annunziata P. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13: 2343-2348, 1999.
36. Weber C, Erl W, Pietsch A, and Weber PC. Aspirin inhibits nuclear factor-B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91: 1914-1917, 1995.
37. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, and Griffin DE. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33: 576-582, 1993.
38. Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Dröge W, and Lehmann V. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J 14: 546-554, 1995.
39. Wiley CA, Baldwin M, and Achim CL. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847, 1996.
40. Woodman SE, Benveniste EN, Nath A, and Berman JW. Human immunodeficiency virus type 1 Tat protein induces adhesion molecule expression in astrocytes. J Neurovirol 5: 678-684, 1999.